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INTRODUCTION: Cardiovascular Disease (CVD) is the leading cause of death in the 
world, even though it can be prevented.  Research has identified many risk factors, 
including cholesterol, physical activity, and abdominal obesity.  The use of ultrasound 
has made it possible to distinguish between visceral adipose tissue (VAT) and 
subcutaneous adipose tissue (SCAT). PURPOSE: To determine the relationship between 
the Framingham CVD risk profile, VAT, SCAT, and physical activity in older adults.  
METHODS: CVD risk factors were measured in 23 males and 39 females ranging in age 
from 39-82.  To determine the Framingham CVD risk score, TC and HDL-C were 
measured and entered into a score calculator.  An ultrasound scan of the abdomen was 
used to determine VAT and SCAT depths.  Pearson’s correlations were done to 
determine associations between all of the variables.  RESULTS: SCAT was significantly 
correlated with the 30-year score, SBP, and TC (r = .342, r = .350, r = .402, p ≤ .01).  
VAT was correlated with PA and SBP (r = -.254, p ≤ .05; r = .395, p ≤ .01). In 
individuals 54 years and under, VAT was correlated with PA and SBP (r = -.447, p ≤ .05; 
r = .602, p ≤ .01). SCAT was correlated with SBP and TC (r = .551, r = .610, p ≤ .01).  In 
individuals over 54 years, SCAT was correlated with the 30-year score (r = .410, p ≤ .05) 
and VAT was correlated with TC (r = -.420, p ≤ .05).  In obese individuals, VAT was 
correlated with PA (r = -.597, p ≤ .05) and SCAT was correlated with the 30-year score (r 
= .770, p ≤ .01).  DISCUSSION: The results show that SCAT was correlated with the 30-
year score, while VAT was correlated with PA.  Age and BMI levels may play a role in 
the effect of abdominal fat on CVD risk.  
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The Framingham Heart Study, established in 1948, is an ongoing research project 
that at its inception identified cardiovascular disease (CVD) risk factors throughout the 
years.  The earliest milestone in the Framingham Heart Study established that cigarette 
smoking was directly related to CVD (Arruda, 2012).  From there, cholesterol levels, 
blood pressure, and obesity were also found to play a role in the development of CVD.  
Today research focuses on the prevention of CV-related diseases.  A 30-year CVD risk 
score has been developed which is used to predict an individual’s risk for CVD (Pencina, 
D’Agostino, Larson, Massaro, & Vasan, 2009).  The score is based on numerous risk 
factors, both modifiable and non-modifiable, including sex and age, body mass index 
(BMI), total cholesterol (TC), systolic blood pressure (SBP), type 2 diabetes, and 
smoking status.  
Current research has focused on how the Framingham CVD risk score is related 
to other factors of CVD, such as abdominal obesity and physical activity levels.  There 
are discrepancies in the literature that make it unclear as to how abdominal obesity and 
physical activity play a role in measuring CVD risk.  While obesity is a known risk factor 
for CVD, it is unclear as to why some seemingly lean individuals are at greater risk of 
CVD than one who is clinically obese (Hamdy, Porramatikul, & Al-Ozairi, 2006; Lopez-
Jimenez et al., 2013; Porter et al., 2009; Stefan et al., 2008).  The distribution of body fat 
and the type of fat storage found in the abdomen may help to determine the degree of 
CVD risk.  Furthermore, physical activity is associated with a more favorable CVD risk 
profile (Ford, 2002).  However, the CVD response to physical activity tends to take 
longer in older individuals (King et al.,1995).   
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Unfavorable lipid profiles are associated with CVD.  The earliest association was 
a positive correlation between TC and CVD (Irzmanski, Sliwczynska-Rodziewicz, 
Pawlicki, & Kowalski, 2012; Ridker, Hennekens, Buring, & Nader, 2000; Wilson, 
Abbott, & Castelli, 1988).  When the components of TC were identified and became a 
routine measurement, cholesterol was classified as “good”, high-density lipoprotein 
cholesterol (HDL-C) and “bad”, low-density lipoprotein cholesterol (LDL-C).  The 
association for LDL-C was positive; as levels increased, so did the risk for CVD.  High-
density lipoprotein cholesterol and CVD were inversely related, showing that as levels 
increased, CVD risk decreased.  At the same time, researchers were questioning the 
association of weight and body fat after positive correlations were found for CVD and 
obesity following the BMI data.  Still, it was not clear whether general obesity was to 
blame or if it was the specific location of the fat in the abdomen, or possibly a 
combination of both.  Perhaps it has to do with some of the non-modifiable risk factors, 
such as sex and age that seemed to change the risk ratio.  For example, males are at 
greater risk than females until after menopause, even when both have equal amounts of 
fat (Spangenburg, Wohlers, & Valencia, 2012).  This led researchers to investigate how 
each of the risk factors are associated to determine a way to predict the risk for CVD.   
Low levels of HDL-C may be directly related to the depth of visceral adipose 
tissue (VAT) in the abdomen.  However, this risk factor becomes less pertinent in older 
individuals due to the theory that as people age, increases in abdominal fat may not be 
correlated with lower HDL-C levels (Ford, 2002).  Thus, the literature is unclear as to 
whether the CVD risk factors are related to increased abdominal fat in older individuals 
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(Nieves et al., 2003; DeNino et al., 2001).  This leads to the question: can older 
individuals with abdominal obesity exhibit a metabolically benign form of abdominal fat?  
The literature is unclear as to whether VAT or subcutaneous adipose tissue 
(SCAT) is responsible for the unfavorable CVD risk profile.  Simple anthropometric 
measurements such as BMI, WC, and WHR are currently used to determine abdominal 
obesity.  Although they are inexpensive and easy to use, these measurements do not 
effectively determine central adiposity and cannot distinguish between VAT and SCAT 
(Lopez-Jimenez et al., 2013; Sogabe, Okahisa, Hibino, & Yamanoi, 2012).  Advances in 
technology have made it possible to measure abdominal fat more effectively.  A variety 
of machines can measure abdominal fat and can identify SCAT from VAT, but until now 
the procedures were expensive.  With a field ultrasound device, researchers are able to 
measure SCAT and VAT separately more efficiently and at a lower cost.   
Physical activity level has both positive and negative effects on CVD risk.  
Research has shown that individuals who partake in leisure time physical activity present 
with a more favorable CVD risk profile (Held et al., 2011).  Improved cholesterol levels, 
BMI, WHR, and inflammatory markers are among the benefits of physical activity 
(Abramson & Vaccarino, 2002; Ford, 2002; Glazer et al., 2012; Held et al., 2011; King, 
Haskell, Young, Oka, & Stefanick, 1995; Manini et al., 2006).  In young adults this 
relationship is widely accepted; however, the literature on older adults is less consistent.  
HDL-C seems to improve with increased physical activity levels in older adults compared 
to TC, BMI, or WHR.  However, the improvements may take longer to elicit a favorable 
CV response (King et al., 1995).  It takes two years for older adults to see improvements 
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in CVD risk, whereas it takes only one year for younger individuals to see similar 
benefits. 
Statement of the Problem 
 Research on CVD prevention is an evolving field of study.  Risk factors continue 
to be identified and are evaluated on their association with the known CVD risk profile.  
Technical advances are also making it possible to measure the risk markers more reliably 
and at lower cost to the researcher.  Cholesterol levels, physical activity levels, and 
abdominal obesity are among the strongest CVD risk markers.  Separating the abdominal 
fat, high levels of VAT are believed to contribute to the development of CVD, while the 
role of SCAT remains controversial.  Finally, the association of advancing age and risk 
markers emphasizes the need to use a cross-section of ages in the research population.  
Therefore, the purpose of this study was to determine the association between the 
Framingham CVD risk profile (TC, HDL-C, SBP, smoking, BMI, sex, and age), SCAT, 
VAT, and physical activity levels in adults over the age of forty. 
Hypothesis 
 The null hypothesis was there would be no significant correlations between the 
Framingham CVD risk profile, SCAT, VAT, and physical activity levels in older adults. 
Operational Definitions 
 Abdominal fat was divided into two compartments: VAT and SCAT.  Visceral 
adipose tissue is the fat that lies in and around the organs, beneath the muscle layer in the 
abdomen.  Subcutaneous adipose tissue is the fat that is stored superficial to the muscle 
layer, just beneath the skin.  The BodyMetrix Pro Systems ultrasonography machine 
(IntelaMetrix, Inc., Livermore, CA) was used to measure VAT and SCAT in mm.  TC 
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and HDL-C were measured in mg/dL in a fasting state using the Cholestech LDX 
Analyzer.  Resting blood pressure was measured in mmHg using an anaeroid 
sphygmomanometer following a five-minute rest period.  Height was measured in inches 
and weight was measured in pounds with a physician’s scale.  These measurements were 
converted to metric units to calculate BMI, using the formula weight in kilograms divided 
by height in meters squared.  
Delimitations 
 This study was delimited to a sample of convenience of 64 males and females 
over 39 years of age.   
Assumptions 
 It was assumed that all participants truthfully and accurately filled out the 
physical activity questionnaire.  It was assumed that the ultrasound machine was a 
reliable and valid measurement of VAT and SCAT. 
Significance  
 It was hoped this study would provide a method of identifying CVD risk earlier, 
and possibly prevent or prolong the onset of CVD.  If so, this may help to compress 
morbidity time, which could positively affect the current health care costs.   
Summary 
 This chapter discussed the evolution of the Framingham Heart Study in CVD risk 
factor analysis.  Several risk factors have been identified and there is still a need for 
research to determine how each of them is associated.  Technological advances have 
made it possible to efficiently and inexpensively evaluate CVD risk.  Thus, the purpose 
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of this study was to determine the association between the Framingham CVD risk profile, 




 CVD is the leading cause of death in the world, even though it can be prevented.  
Research has identified risk factors to aid in the diagnosis and prevention of CVD.  
Cholesterol levels, physical activity levels, and abdominal obesity are among the 
strongest CVD risk markers (Arruda, 2012).  High levels of VAT are believed to 
contribute to the development of CVD, while the role of SCAT remains controversial 
with respect to CVD risk.  The purpose of this study was to determine the association 
between the Framingham CVD risk profile, SCAT, VAT, and physical activity levels in 
older adults.  This chapter discusses the associations between these four risk factors and 
CVD.    
Framingham CVD Risk Profile 
 The Framingham Heart Study is an ongoing research project that began in 1948.  
When it began, CVD was just beginning to expand as Americans were living longer.  No 
research had yet identified risk factors for the disease that were specifically associated 
with certain lifestyle behaviors.  The original study consisted of adults aged 30-62, who 
have been evaluated annually with respect to CV-related diseases and mortality over their 
lifespan (Arruda, 2012).  A secondary study evolved when the need for establishing 
guidelines for a younger population was identified.  This study is known as the Offspring 
Study, and participants include the children of the original cohort.  Once the researchers 
felt confident in the various risk factors identified, they wanted to use this cohort to 
determine the existence of genetic variables that may be related to CVD (Arruda, 2012).   
9 
 Today, the research is focused on determining ways to predict an individual’s risk 
of CVD by combining risk factors from previous data.  Researchers developed a method 
to predict the 30-year risk score for CVD using identified risk factors from the 
Framingham Offspring Study (Pencina et al., 2009).  The risk factors included in this 
score are sex, age, systolic blood pressure (SBP), BMI, TC, HDL-C, diabetes, smoking 
status, and treated hypertension (Pencina et al., 2009).  Each of these risk factors has been 
identified as independently related to CVD, although CVD risk increases exponentially 
when these risk factors are combined.  This grouping of risk factors has been named the 
metabolic syndrome when the variables are combined (Carnethon et al., 2004).  The 
degree of CVD risk is simply evaluated by how many risk factors each individual 
possesses and is diagnosed when at least three are combined. 
 Framingham risk factors 
 Risk factors for CVD can be classified as either fixed (non-modifiable) or 
modifiable.  Fixed risk factors are those that cannot be altered to improve CVD risk, such 
as age, sex, and treated hypertension.  Modifiable risk factors are those that can be 
changed to improve the CVD risk profile of an individual.  These include cholesterol, 
smoking status, and BMI.  Cholesterol is a modifiable risk factor that is frequently used 
in research as the focus for CVD prevention (Irzmanski et al., 2012; Rein, Saley, Beer, 
Vonbank, & Drexel, 2010; Ridker et al., 2000; Wilson et al., 1988). 
 Cholesterol can be separated into two types: LDL-C and HDL-C.  LDL-C is 
considered “bad” cholesterol because it consists mostly of lipids with a few protein 
components (McArdle et al., 2007).  LDL-C molecules are attracted to the arterial wall, 
causing an unfavorable condition of narrowing the blood vessel (McArdle et al., 2007).  
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Therefore high levels found in the bloodstream are associated with increased 
cardiovascular risk.  HDL-C is commonly referred to as “good” cholesterol because they 
remove cholesterol from the arterial walls and transport it to the liver where it is 
metabolized or excreted (McArdle et al., 2007; Silverthorn, 2004).  As a result high levels 
of HDL-C decrease cardiovascular risk (Silverthorn, 2004).  High levels of LDL-C, 
represented as TC, and low levels of HDL-C are included in the CVD risk profile due to 
their effects on the cardiovascular system. 
Table 1   
ACSM’s criteria for CVD risk factors 
Risk Factors Criteria 
1. Family history Myocardial infarction, coronary 
revascularization, or sudden death before 55 
years of age in father or other male first degree 
relative, or before 65 years of age in mother or 
other female first degree relative 
 
2. Cigarette smoking Current or those who quit within the previous 6 
months 
 
3. Hypertension SBP ≥ 140 mmHg or DBP ≥ 90mmHg, or on 
antihypertensive medication 
 
4. Dyslipidemia LDL-C ≥130 mg/dL, HDL-C <40 mg/dL, or 
TC≥200 mg/dL 
Negative risk factor: HDL-C≥60 mg/dL 
 
5. Impaired fasting glucose Fasting blood glucose ≥100 mg/dl 
 
6. Obesity BMI ≥30 kg/m
2
 or WC >102 cm for men and > 
88 cm for women or WHR ≥0.95 for men and 
≥0.86 for women 
 
7. Sedentary lifestyle Persons not participating in a regular exercise 
program or not meeting the minimal physical 
activity recommendations from the U.S. Surgeon 
General’s Report 
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 The American College of Sports Medicine risk stratification for individuals who are 
at risk for CVD has defined the criteria for each risk factor (Table 1) (Armstrong et al., 
2006).  This is supported in the literature as most researchers have found that HDL-C is 
inversely correlated with CVD risk, while TC and LDL-C are directly associated with 
CVD risk (Irzmanski et al., 2012; Rein et al., 2010; Ridker et al., 2000; Wilson et al., 
1988).  In older adults, low levels of HDL-C are associated with increased coronary 
mortality.  HDL-C is a strong predictor of CV related death, a finding that is less 
consistent with other types of death (Wilson et al., 1988).  This association is the 
strongest at the lowest levels of HDL-C (Wilson et al., 1988).  When participants were 
matched for similar baseline characteristics, TC and LDL-C levels were significantly 
higher among women with a history of CV events compared to those without CV events 
(Ridker et al., 2000).  Individuals with a history of CV events also present with lower 
levels of HDL-C compared with those without CV events (Ridker et al., 2000).  One 
theory suggests that BMI is inversely related to HDL-C, suggesting that leaner 
individuals have higher levels of HDL-C, thus are at less risk for CVD and coronary 
mortality (Wilson et al, 1988).  
 Furthermore, the metabolic syndrome is closely related to CVD.  The metabolic 
syndrome is identified by visceral adiposity, unfavorable lipid profiles, and high levels of 
inflammation, similar to CVD (Carnethon et al., 2004).  HDL-C is negatively correlated 
with vascular complications in individuals with the metabolic syndrome (Irzmanski et al., 
2012; Rein et al., 2010).  Evidence suggests that HDL-C is strongly associated with the 
metabolic syndrome and is an independent predictor of CV events (Rein et al., 2010).  
Elevated levels of HDL-C have a protective influence on blood vessels, specifically by 
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reversing cholesterol transport in the blood (Irzmanski et al., 2012; Rein et al., 2010).  
HDL-C particles are also negatively correlated with inflammatory markers, consequently 
lessening the pressure on arterial walls and protecting them from adverse CV events 
(Rein et al., 2010).  In individuals with the metabolic syndrome, higher levels of HDL-C 
may help prevent CV incidents (Irzmanski et al., 2012).   
Abdominal Obesity 
 Current research suggests that obesity is linked to CVD.  Individuals who carry 
excess body weight are at a greater risk for CVD and death (Stevens et al., 1998).  
Researchers from the Framingham Heart Study suggested that obesity, measured as a 
percentage of desirable weight, is an independent predictor of CVD (Hubert, Feinleib, 
McNamara, & Castelli, 1983).  This finding was greater among women, although it was 
significant for men as well.  General obesity is not a specific enough measure to 
determine if an individual is at risk for CVD, however.  Body fat distribution plays an 
important role in determining CVD risk.  Individuals with greater abdominal fat are at a 
higher risk than those with greater lower body fat (Porter et al., 2006; Stefan et al., 2008).  
Still, this is not a definitive measurement to determine CVD risk.   
 Current research is focused on distinguishing between metabolically benign obesity 
and obesity that is detrimental to CV health (Angeras et al., 2012; Hamdy et al., 2006; 
Porter et al., 2009; Stefan et al., 2008; Stevens et al., 1998;).  Using BMI as a 
measurement of obesity, there is evidence that the body may have a protective fat depot 
(Angeras et al., 2012).  Underweight and normal-weight individuals with acute coronary 
syndromes have the highest risk of mortality compared to overweight or obese 
individuals (Angeras et al., 2012).  There is evidence to suggest that an individual may be 
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clinically overweight and still have a lower risk for mortality than a normal or under-
weight individual (Flegal, Graubard, Williamson, & Gail, 2007).  This supports the 
theory of a protective fat depot when BMI is used to calculate obesity.  Similarly, a 
normal-weight individual with excess abdominal fat is at greater risk for death than an 
obese individual with less abdominal fat (Lopez-Jimenez et al., 2013).  Thus, an 
apparently lean individual may be at a higher risk for CV related events than one who is 
clinically obese, depending on the distribution of body fat (Hamdy et al., 2006; Porter et 
al., 2009; Stefan et al., 2008).  
 VAT vs. SCAT 
 There are discrepancies in the research with respect to the two types of fat found in 
the abdomen and their relationship to CVD risk.  Most researchers agree that greater 
amounts of VAT increase CVD risk (Demerath et al., 2008; Fox, 2007; Liu et al., 2010).  
However, it remains controversial as to whether or not SCAT is associated with CVD 
risk, or if it is beneficial.  The literature suggests that obesity may be a determinant of the 
lipoprotein profile (Nieves et al., 2003). There is evidence that VAT increases with age 
and that this relationship may be responsible for the unfavorable lipid profiles that 
increase the CVD risk in older individuals (DeNino et al., 2001).  BMI is positively 
associated with CVD risk, demonstrated by increasing triglycerides and decreasing HDL-
C, but is not associated with unfavorable LDL-C levels (Nieves et al., 2003).  More 
specifically, increases in VAT are associated with a more atherogenic lipid profile, 
defined by an increase in triglycerides, TC, and LDL-C, and a decrease in HDL-C 
(Nieves et al., 2003).  This relationship is also positively associated with age and VAT 
progressively increases with age (DeNino et al., 2001).  One theory for the age-related 
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association in females is the hormonal changes that occur after menopause.  A lack of 
estrogen seems to be strongly associated with increases in visceral fat cell size, thus 
rapidly increasing the risk for CVD (Spangenburg et al., 2012).  This is associated with 
unfavorable changes in the lipid profile, including increasing LDL-C and TC levels 
(DeNino et al., 2001).  Unfavorable changes in lipid profiles and increasing levels of 
VAT are also associated with a moderate decrease in insulin sensitivity (DeNino et al., 
2001; Nieves et al., 2003).  Thus, reducing VAT will help to improve lipid profiles and 
insulin sensitivity, especially in older adults (DeNino et al., 2001; Nieves et al., 2003).   
 The literature suggests that VAT is a reliable predictor of CVD risk, independent of 
BMI (Fox et al., 2007; Liu et al., 2010; Smith, J. et al., 2012; Taksali, S. E. et al., 2008).  
In a population of adolescents with similar BMI scores, those with greater VAT were at a 
higher risk for metabolic complications (Taksali et al., 2008).  One study determined that 
while BMI is not related to LDL-C, VAT is positively associated with LDL-C and TC, 
suggesting that VAT is a better indicator of a more atherogenic lipid profile that increases 
CVD risk (Nieves et al., 2003).  Increasing levels of VAT is associated with unfavorable 
lipid profiles, including higher levels of triglycerides and lower levels of HDL-C (Nieves 
et al., 2003; Smith et al., 2012).  These findings are consistent in individuals with and 
without type 2 diabetes (Smith et al., 2012).  Furthermore, the evidence suggests that 
VAT is a better independent predictor of CV related diseases than SCAT (Demerath et 
al., 2008).   
 With respect to SCAT, the evidence is controversial.  Some researchers have found 
that increasing levels of SCAT are accompanied with a higher CVD risk score (Fox et al., 
2007; Liu et al., 2010).  This theory is justified with the evidence that the amount of 
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SCAT is directed related to the amount of VAT.  Conversely, other researchers believe 
that SCAT is beneficial to CV health, specifically in individuals with unfavorable lipid 
profiles (Porter et al., 2009; Smith et al., 2012; Taksali et al., 2008).  Elevated levels of 
SCAT tend to be more protective against CV related diseases as levels of VAT increase 
(Demerath et al., 2008; Porter et al., 2009).  Triglyceride levels tend to decrease with 
greater amounts of SCAT, although this is only evident in individuals with the highest 
levels of VAT (Porter et al., 2009).  Conversely, Taksali et al. (2008) found that those 
with higher levels of SCAT tend to have lower levels of VAT.  These individuals exhibit 
a more favorable metabolic profile (Taksali et al., 2008).  The evidence is unclear as to 
whether the higher levels of SCAT or the lower levels of VAT are responsible for the 
improved lipid profile.   
 Measurement tools 
 Current guidelines for measuring abdominal obesity include BMI with waist 
circumference (WC) and waist-to-hip ratio (WHR).  These measurements are easily 
attainable and do not require expensive equipment; however, they are not reliable 
methods to measure abdominal fat, they are estimates at best.  BMI is a ratio of height 
and weight, but it does not take into account body fat distribution or muscle mass (Lopez-
Jimenez et al., 2013).  A seemingly thin individual with normal BMI and excess 
abdominal fat is likely to have less muscle mass as well, an indication of a lower fitness 
level (Lopez-Jimenez et al., 2013).  WC is often used in addition to BMI to determine if 
there is a greater amount of fat around the abdomen.  The WHR operates on a similar 
concept, comparing the girth around the hips to abdominal girth, assuming that these 
measurements reflect the amount of fat mass in the respective areas.  Still, none of these 
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methods can accurately assess the amount of fat in the abdomen, nor can they 
differentiate between VAT and SCAT.  While an MRI or CT scan is the gold standard for 
measuring VAT and SCAT separately, these methods are expensive and not readily 
available to clinicians as a preventative screening tool (Hamdy et al., 2006).  Valsamakis 
et al. (2004) sought to determine the best anthropometric measure that most closely 
relates to the results of an MRI or CT scan.  They determined that WC is the best 
measure compared with BMI and/or WHR (Valsamakis et al., 2004).  However, WC 
cannot effectively distinguish between SCAT and VAT, thus it is not an accurate 
measurement of obesity as a CVD risk factor (Sogabe et al., 2012).   
 Ultrasonography is a reliable method for measuring VAT and SCAT (Gong et al., 
2007; Hirooka et al., 2005; Johnson, Naccarato, Corder, & Repovich, 2012; Sogabe et al., 
2012).  The BodyMetrix is an ultrasound machine that can determine body fat percentage 
as accurately as bioelectrical impedance (BIA) and air displacement plethysmography 
(Johnson et al., 2012; Shojaei et al., 2010).  The BodyMetrix also has the ability to 
distinguish between VAT and SCAT, which makes it a more desirable measure to 
determine CVD risk.  In a study that measured VAT by determining the depth of the 
perirenal fat deposits, the ultrasonic measurement was equivalent to that of the MRI scan 
(Gong et al., 2007).   Compared with computed tomography, ultrasonography is equally 
effective in measuring VAT and SCAT (Hirooka et al., 2005).  However, the accuracy of 
ultrasonography is dependent on the ability of the operator to be precise and consistent 
with the measurements (Shojaei et al., 2010).  The ultrasound operators need to be trained 
for proper scanning technique and should have adequate knowledge of the anatomical 
landmarks around the area being measured (Shojaei et al., 2010). 
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Physical Activity Level 
 The American College of Sports Medicine guideline for exercise prescription states 
that adults aged 18-65 years need a minimum of 30 minutes of moderate-intensity aerobic 
exercise on five days each week, or a minimum of 20 minutes of vigorous-intensity 
aerobic exercise on three days each week (Haskell et al., 2007).  Muscular strengthening 
exercises should be performed at least two days per week (Haskell et al., 2007).  This 
protocol is recommended to promote and maintain a healthy lifestyle.   
 Researchers have determined that individuals who partake in regular exercise have 
lower CVD risk (Abramson & Vaccarino, 2002; Ford, 2002; Glazer et al., 2012; Held et 
al., 2011; King et al., 1995; Manini et al., 2006).  Current literature suggests that physical 
activity level is inversely related to TC, WHR, BMI, and C-reactive protein levels (Ford, 
2002).  This association was prevalent in a younger population; however, there is 
discrepancy in the literature with respect to older adults (King et al., 1995).  The HDL-C 
may be a more accurate measure of physical activity on CVD risk for older adults.  The 
evidence suggests that HDL-C is directly associated with physical activity level in both 
younger and older adults (Ford, 2002; Glazer et al., 2012; King et al., 1995).  However, it 
may take longer for older adults to see a significant change in the lipid profile.  In a study 
of men and women ages 50-65 years, HDL-C improved significantly over a two-year 
period of regular exercise (King et al., 1995).  These results are similar to those of a 
younger population over a one-year period of regular exercise, indicating that the benefits 
of exercise take more time to evolve in older individuals.  Older adults who demonstrate 
a higher energy expenditure and resting metabolic rate have a lower risk of mortality 
(Manini et al., 2006).   
18
 Evidence suggests that more frequent, shorter bouts of exercise have a greater CV 
benefit than less frequent, prolonged exercise (Abramson & Vaccarino, 2002; Glazer, et 
al., 2012; King et al., 1995).  Shorter bouts of physical activity are significantly related to 
a lower Framingham CVD risk score (Glazer et al., 2012).  Researchers found a stronger 
association between the frequency of exercise and HDL-C levels compared to the 
intensity of exercise and HDL-C levels (King et al., 1995).  Similarly, Abramson and 
Vaccarino (2002) determined that individuals who participate in regular exercise more 
frequently have lower levels of C-reactive protein and other inflammatory markers.  
Increased levels of HDL-C and decreased levels of C-reactive protein are beneficial to 
CV health.  Physical activity levels are significantly correlated with a lower prevalence of 
obesity (Glazer et al., 2012).  Lower waist circumference, BMI, and triglycerides are 
associated with physical activity, independent of duration (Glazer et al., 2012).  However, 
leisure time physical activity is more beneficial to CV health than occupational physical 
activity (Held et al., 2011).  The INTERHEART study determined that individuals who 
partake in occupational physical activity exhibit more CVD risk markers than those who 
participate in leisure time physical activity (Held et al., 2011).  The theory behind this 
finding is that occupational physical activity is more anaerobic than aerobic, such as 
heavy lifting.  Anaerobic activity is not as beneficial to CV health.  Overall, physical 
activity is associated with favorable metabolic profiles that improve CV health.   
Summary  
 The literature presents evidence that CVD risk is an area that requires continuous 
research to develop preventative measures to decrease such risk.  Abdominal obesity is 
associated with lipid profiles and physical activity; however, the evidence linking VAT 
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and SCAT to CVD risk is unclear.  With improvements in technology, the use of 
ultrasound has recently been introduced as a way of distinguishing between VAT and 
SCAT.  Thus, with the use of ultrasound, the purpose of this study was to determine the 
association between the Framingham CVD risk profile, SCAT, VAT, and physical 




The purpose of this study was to determine the relationship between the 
Framingham CVD risk profile, SCAT, VAT, and physical activity levels in adults older 
than 40 years of age.  Specifically, we used ultrasonography to determine whether SCAT 
or VAT is a better indicator of abdominal obesity as a risk factor for CVD compared to 
the Framingham CV risk profile. This chapter describes the methodology that was 
employed to test the hypotheses of the current study.  The methodology includes 
participant recruitment, information on the instrumentation used, an overview of the 
procedures, and a description of the statistical analysis that was performed. 
Participants 
 A convenience sample of 64 volunteers was recruited for the present study 
through flyers, word of mouth, and referrals. This study was delimited to males and 
females over the age of 39 with no restriction for current disease diagnosis.  The 
Institutional Review Board for Human Subjects at Eastern Washington University 
approved this study prior to recruitment.  The detailed descriptive statistics of the study 









Variable Mean ± Standard Deviation 
Age (yrs)                         56.16 ± 9.64 
Height (in) 67.05 ± 3.63 
Weight (lbs) 173.91 ± 40.11 
BMI (kg/m
2
)                         27.13 ± 5.80 
SBP (mmHg)                       118.77 ± 9.82 
Physical Activity (min/day)                         35.16 ± 22.83 
TC (mg/dl)                       203.03 ± 40.43 
HDL-C (mg/dl)                         61.52 ± 19.31 
VAT (cm)                         19.40 ± 8.31 
SCAT (cm)                         13.63 ± 7.40 
Total US (cm)                         33.03 ± 12.95 
30-yr. Risk Score (%)                         30.70 ± 15.14 
 
Instrumentation 
 The following variables were collected for each participant: height, weight, age, 
sex, current medications, smoking status, blood pressure, HDL-C, TC, VAT, SCAT, and 
physical activity level.  Age, sex, current medications, smoking status, and physical 
activity levels were collected via a questionnaire, given orally by the researchers.   
 Blood pressure was measured manually with a standard anaeroid 
sphygmomanometer and stethoscope.  Height and weight were measured with a standard 
physician’s scale (Cardinal Manufacturing Company, Webb City, MO) and stadiometer.  
A Cholestec LDX blood analyzer (Cholestec Corporation, Hayward, CA) was used to 
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measure TC and HDL-C. VAT and SCAT were measured with a BodyMetrix Pro System 
ultrasonography machine (IntelaMetrix, Inc., Livermore, CA).   
Procedure 
 The purpose of the study was explained and all questions were answered at the 
time of recruitment.  Participants were asked to fast for 12 hours prior to testing.  All 
testing took place in the Human Performance Lab at Eastern Washington University.  
Upon entering the lab, participants were briefed again on the procedures of the study.  
They were asked to sit down and rest for five minutes, during which time they signed the 
informed consent and completed the physical activity questionnaire.  Once the participant 
had been seated for at least five minutes the participant’s blood pressure was measured.  
Height and weight were then measured and recorded. A small blood sample (35 
microliters) was taken from a finger stick to measure TC and HDL-C.  The finger stick 
was performed using a sterile lancet, collecting enough blood to fill the capillary tube.  
The blood was then transferred to an analyzer cassette and placed in the Cholestech LDX 
Analyzer.  The final procedure was the ultrasound scan of the abdomen to assess VAT 
and SCAT.  A 4 cm horizontal scan across the abdomen at a level of the umbilicus was 
performed, starting 1 cm to the right of the umbilicus to measure the VAT and SCAT 
levels.  All data was collected on a separate data collection sheet, void of any identifiers 
to prevent bias.  The data was then entered into a Microsoft Excel spreadsheet before 
being imported into SPSS.  Participants received a handout with their results as well as 
educational material for their reference.  
Analysis 
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 Statistical analysis was performed using SPSS version 20 software.  Data was 
screened for outliers and checked for normality.  Descriptive statistics were provided for 
both males and females on all variables and frequencies were calculated to determine the 
distribution of each of the variables.  Pearson’s correlations were used to examine the 
relationships between the Framingham CVD risk profile, all independent variables 
included in the risk profile, SCAT, VAT, and physical activity.  Partial Pearson’s 
correlations were calculated to adjust for age and BMI.   
Summary 
 This chapter presented the methods and procedures that were conducted for this 
study.  Participants and instrumentation were identified, as well as a description of the 




The purpose of this study was to determine the relationship between the 
Framingham CVD risk profile, SCAT, VAT, and physical activity levels in older adults.  
Specifically, we used ultrasonography to determine whether SCAT or VAT is a better 
indicator of abdominal obesity as a risk factor for CVD compared to the Framingham CV 
risk profile.  This chapter discusses the results of the current study. 
The detailed descriptive statistics of the study population are included in Table 2.   
A total of 64 participants were recruited for this study.  Two participants were unable to 
complete all the data collection, thus were excluded from the study.  This study consisted 
of 23 males and 39 females aged 39-82.  The data was normally distributed, thus 
Pearson’s correlations were calculated to determine relationships among the variables. 
Initially, the entire population was analyzed to determine correlations between 
VAT, SCAT, Framingham CVD risk score, and physical activity levels (Table 3).  There 
was a significant moderate positive correlation between VAT and SCAT (r = .355, p = 
.005) as well as between SCAT and the Framingham CVD risk score (r = .342, p = .007).   
Physical activity was negatively correlated with VAT (r = -.254, p = .047).  There were 
no significant correlations between VAT and the Framingham CVD risk score, nor were 
there significant correlations between physical activity and SCAT or the Framingham 
CVD risk score. 
 
 
Table 3  
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Correlations between VAT, SCAT, 30-year risk score, and physical activity (PA) 
 VAT SCAT Total US 30-yr Risk PA 
VAT 1     
SCAT     .355** 1    
Total US     .845**     .800** 1   
30-yr Risk .059     .342** .238 1  
PA -.254*      -.209 -.282* .037 1 
*Significant at an alpha level p • .05 
**Significant at an alpha level p • .01 
The data was then split into two age groups: individuals aged 54 and under and 
individuals aged 55 and over.  This was determined by the median age of 54.  In 
individuals aged 54 and under, there were no significant correlations with respect to the 
Framingham 30-year risk score (Table 4).  VAT was significantly correlated with SCAT 
(r = .469, p = .005) and physical activity (r = -.447, p = .012).  Physical activity was 
negatively correlated with the total US measurement (r = -.392, p = .029).  In individuals 
ages 55 and over, the only significant correlation was found between SCAT and the 
Framingham CVD risk score (r = .410, p = .022).  There were no significant correlations 





Table 4  
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Correlations between VAT, SCAT, 30-year risk score, and physical activity in individuals 
age 54 and under 
 VAT SCAT Total US 30-yr Risk PA 
VAT 1     
SCAT .496** 1    
Total US .884**     .844** 1   
30-yr Risk     .135 .256 .225 1  
PA    -.447*      -.215  -.392*      -.016 1 
*Significant at an alpha level p • .05 
**Significant at an alpha level p • .01 
 The data was then stratified into four levels by BMI measurements: underweight 
(BMI < 18.5), normal-weight (BMI = 18.5-24.9), overweight (BMI = 25-29.9), and obese 
(BMI  ≥ 30).  There was only one participant in the underweight group, thus that group 
was excluded.  The remaining three groups had sufficient numbers in the n list (n = 23, n 
= 23, n = 14 respectively) for analysis.  The normal and overweight groups did not yield 
any significant correlations between VAT, SCAT, total US, Framingham CVD risk score, 
or physical activity (Table 5).  In the obese group, there was a significant negative 
correlation between VAT and physical activity (r = -.597, p = .028).  The Framingham 
CVD risk score was positively correlated with SCAT (r = .770, p = .001) and total US (r 
= .719, p = .006).  There were no significant correlations between VAT and physical 
activity with respect to the Framingham CVD risk score (Table 6). 
 
Table 5  
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Correlations between VAT, SCAT, 30-year risk score, and physical activity in normal 
weight individuals (BMI = 18.5-24.9) 
 VAT SCAT Total US 30-yr Risk PA 
VAT 1     
SCAT   .441* 1    
Total US     .887**    .805** 1   
30-yr Risk .174 .092 .162 1  
PA .132 .024 .100 .255 1 
*Significant at an alpha level p • .05 
**Significant at an alpha level p • .01 
Table 6 
Correlations between VAT, SCAT, 30-year risk score, and physical activity in obese 
individuals (BMI • 30) 
 VAT SCAT Total US 30-yr Risk PA 
VAT 1     
SCAT .347 1    
Total US    .830**    .811** 1   
30-yr Risk .402    .770**    .719** 1  
PA -.597*     -.215     -.500     -.183 1 
*Significant at an alpha level p • .05 
**Significant at an alpha level p • .01 
Further analysis sought to determine the relationship between VAT, SCAT, total 
US, and physical activity on the Framingham CVD risk score and its individual 
components, including sex, age, SBP, TC, and HDL-C.  Analysis of the entire sample 
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yielded significant correlations with respect to sex, SBP, and TC (Table 7).  Sex was 
negatively correlated with SCAT (r = -.413, p = .001) and total US (r = -.324, p = .010).  
SBP was positively correlated with VAT (r = .395, p = .001), SCAT (r = .350, p = .005), 
and total US (r = .454, p = .000).  TC was positively correlated with SCAT (r = .402, p = 
.001). 
Table 7  
Correlations between the 30-year Risk Score variables (sex, age, SBP, TC, and HDL-C) 
and VAT, SCAT, Total US, and PA 
 Sex Age SBP TC HDL-C 
VAT -.138 -.141    .395**      -.036      -.036 
SCAT     -.413**  .051    .350**     .402** .140 
Total US   -.324* -.061    .454** .207 .057 
PA -.101  .081      -.178      -.186 .017 
*Significant at an alpha level p • .05 
**Significant at an alpha level p • .01 
  In individuals aged 54 and under, there were no significant correlations with 
respect to age and HDL-C as they relate to VAT, SCAT, and physical activity (Table 8).  
There were significant negative correlations between total US and sex (r = -.359, p = 
.048), as well as between physical activity and SBP (r = -.386, p = .032).  Significant 
correlations were found between SCAT and sex (r = -.503, p = .004), SBP (r = .551, p = 
.001), and TC (r = .610, p = .000).   VAT and SBP were positively correlated as well (r = 
.602, p = .000).  Total US was positively correlated with SBP (r = .668, p = .000) and TC 
(r = .487, p = .006).  For individuals over the age of 54, there were no significant 
correlations with respect to sex, age, SBP, or HDL-C.  The only significant correlation 
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that was found for this age group was a negative correlation between VAT and TC (r = -
.420, p = .019).  
Table 8 
Correlations between the 30-year Risk Score variables (sex, age, SBP, TC and HDL-C) 
and VAT, SCAT, Total US, and PA in individuals age 54 and under 
 Sex Age SBP TC HDL-C 
VAT -.143 -.149    .602** .256      -.102 
SCAT     -.503**  .074    .551**    .610** .190 
Total US   -.359* -.052    .668**    .487** .039 
PA .116 -.131 -.386*     -.258 .140 
*Significant at an alpha level p • .05 
**Significant at an alpha level p • .01 
 After stratification of the sample into three groups based on BMI, significant 
correlations were found for the normal and obese groups, but not the overweight group.  
In obese individuals, SCAT was negatively correlated with sex (r = -.697, p = .009) and 
positively correlated with SBP (r = .780, p = .007) (Table 9).  VAT was positively 
correlated with SBP (r = .625, p = .017), and total US was positively correlated with SBP 
(r = .854, p = .000).  Physical activity was positively correlated with age (r = .713, p = 
.004) and negatively correlated with SBP (r = -.574, p = .032).  Normal weight 
individuals did not yield significant correlations with respect to VAT and physical 
activity (Table 10).  SCAT was positively correlated with HDL-C (r = .476, p = .022) and 
negatively correlated with sex, and these correlations were significant (r = -.440, p = 
.036).  Total US was negatively correlated with sex as well (r = -.438, p = .037).   
Table 9 
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Correlations between the 30-year Risk Score variables (sex, age, SBP, TC, and HDL-C) 
and VAT, SCAT, Total US, and PA in obese individuals (BMI • 30) 
 Sex Age SBP TC HDL-C 
VAT -.256 -.493 .625*     -.145      -.093 
SCAT    -.697**  .053  .780** .404 .217 
Total US  -.574* -.276  .854** .150 .071 
PA .053    .713**    -.574*     -.191 .144 
*Significant at an alpha level p • .05 
**Significant at an alpha level p • .01 
Table 10  
Correlations between the 30-year Risk Score variables (sex, age, SBP, TC, and HDL-C) 
and VAT, SCAT, Total US, and PA in normal weight individuals (BMI = 18.5-24.9) 
 Sex Age SBP TC HDL-C 
VAT -.321      -.121 .163      -.053 .149 
SCAT  -.440* .040      -.082 .257   .476* 
Total US  -.438*      -.059 .065 .097 .343 
PA .040 .106 .065 .016      -.228 
*Significant at an alpha level p • .05 
Summary  
Overall, the results of this study refuted the null hypothesis that there would be no 
significant associations between the Framingham CVD risk score, SCAT, VAT, and 
physical activity in older adults.  There were significant correlations between SCAT and 
the Framingham CVD risk score in individuals over 54 years old as well as in obese 
individuals.  VAT remained insignificant with respect to the Framingham CVD risk score 
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in all the groups.  Physical activity was negatively correlated with VAT, and this 




The purpose of this study was to determine the relationship between the 
Framingham CVD risk profile, SCAT, VAT, and physical activity levels in older adults.  
Specifically, we used ultrasonography to determine whether SCAT or VAT is a better 
indicator of abdominal obesity as a risk factor for CVD compared to the Framingham 
CVD risk profile.  This chapter discusses the outcomes of the study and provides 
recommendations for future research on this topic.   
Principal Findings 
The Framingham CVD risk score, developed by researchers from the 
Framingham Heart Study, is a way to predict an individual’s 30-year risk for being 
diagnosed with CVD (Pencina et al., 2009).  Being able to assess CVD risk early may 
help to prevent or delay the onset of the disease.  Since many of the risk factors are 
lifestyle related, an individual will have more time to change behavior and reduce risk.  
The original Framingham Study and more recently the Offspring Study identified 
numerous risk factors that are linked to the chance of developing CVD (Pencina et al., 
2009).  Through a statistical analysis to identify the strengths of the associations of the 
various risk factors, the Framingham CVD risk score is comprised of the strongest of 
these variables, some of which can be modified to improve the CVD risk score.  The 
variables include sex, age, SBP, TC, HDL-C, BMI, smoking status, and treated 
hypertension (Pencina et al., 2009).  These variables are entered into a calculator 
available on the Framingham website (www.framinghamheartstudy.org) that generates a 
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score representing CVD risk.  The score represents CVD risk as a percentage, estimating 
the probability of developing CVD within 30 years.   
In the current study, the results show that VAT is positively correlated with 
SCAT, although this relationship is weak (r = .355, p = .005).  Surprisingly, SCAT, but 
not VAT, was positively correlated (albeit weakly) with the Framingham CVD risk score 
(r = .342, p = .007).  After breaking the Framingham CVD risk score down into its 
individual components, SCAT remained significantly correlated with sex (r = -.413, p = 
.001), SBP (r = .350, p = .005), and TC (r = .402, p = .001), while VAT was only 
correlated with SBP (r = .395, p = .001).  Past research has yielded similar results as the 
present study, determining that the amount of SCAT is directly related to the amount of 
VAT, and that both VAT and SCAT are associated with CVD risk (Fox et al., 2007; Liu 
et al., 2010). The CVD risk factors that were included in these studies are similar to those 
that were measured in the present study.  Fox et al. (2007) used the Framingham Heart 
Study guidelines to determine the risk factors.  These researchers used larger sample sizes 
of a similar age group as the current study.  Other than the sample size, the population of 
the current study was similar to that of Fox et al. (2007) with respect to hypertension and 
diabetes.  The participants in the Jackson Heart Study did not have CVD, however over 
half of them were obese and had been diagnosed with the metabolic syndrome (Liu et al., 
2010).  Unlike the sample in the current study, most of the participants also had 
hypertension (Liu et al., 2010).   
The findings of the current study failed to support the theory that VAT is more 
strongly associated than SCAT with increased CVD risk, which many researchers have 
determined (Demerath et al., 2008; Fox et al., 2007; Liu et al., 2010; Smith et al., 2012; 
34
Taksali et al., 2008).  Most of these studies used a CT scan rather than ultrasound to 
measure VAT and SCAT, which may account for some of the inconsistencies between 
the current study and previous research.  Also, most previous studies evaluated 
populations that were either overweight or obese, on average, while the current study was 
a mix of all weights and fitness levels.  It is possible that fitness may be a stronger 
correlate than weight for risk, which has led to the “fit and fat” theory (Flegal et al., 
2007).   
Contrary to the current findings, Demerath et al. (2008) suggests that VAT is a 
better predictor of CVD than SCAT.  This association was found in a larger sample with 
an average age that was 13 years younger than the average age in the current study.  In 
adolescents, high levels of VAT with low levels of SCAT provided evidence of a 
phenotype for partial lipidystrophy (Taksali et al., 2008).  These individuals were at 
greater risk for CVD and the metabolic syndrome at an age not generally associated with 
CVD (Taksali et al., 2008).  While the population of the present study was older, greater 
than 40 years, there was no restriction based on current health status.  Thus, while age is 
one of the non-modifiable risk factors for CVD and VAT is strongly associated as well, 
there may be another variable with a stronger influence that was not identified in the 
present study.  One study found that SCAT is strongly associated with CVD risk only in 
those with the highest levels of VAT (Porter et al., 2009).  The current study may not 
have had enough participants with great amounts of VAT to see this effect, as the sample 




Effect of BMI 
Further analysis indicated that these correlations grew stronger after stratifying 
the sample into groups based on BMI.  Three groups were identified: normal-weight 
(BMI = 18.5-24.9), overweight (BMI = 25-29.9), and obese (BMI ≥ 30).  The obese 
group yielded a strong positive correlation between SCAT and the Framingham CVD risk 
score (r = .770, p = .003), as well as with SBP (r = .780, p = .003).  The total ultrasound 
measurement yielded a strong positive correlation with the Framingham CVD risk score 
(r = .719, p = .006) as well, suggesting that total abdominal fat may be more atherogenic 
than VAT or SCAT alone.  Interestingly, SCAT was positively correlated with HDL-C in 
the normal weight group (r = .476, p = .022), adding to the literature that SCAT may have 
beneficial effects on CVD risk (Hamdy et al., 2006).  Still, VAT was not significantly 
correlated with the Framingham CVD risk score in any of the BMI groups.  The 
overweight group did not yield any significant correlations with the Framingham CVD 
risk score or any of the variables measured as a part of the score, providing additional 
evidence to the “fit and fat” theory (Flegal et al., 2007).  
The “fit and fat” theory supports the idea that overweight is the new normal.  The 
growing trends in America today suggest that on average, people are weighing more than 
they used to.  Research suggests that overweight, but not obese, individuals are less likely 
to develop CVD and may live longer than one who is clinically normal-weight (Flegal et 
al., 2007).  In a more recent review, it was also determined that those in the highest levels 
of obesity are at greater risk for mortality, whereas overweight is associated with lower 
mortality, and even the lowest level of obesity was not associated with mortality (Flegal 
et al., 2013).  The current study suggests that overweight individuals can still be fit 
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according to CVD risk.  Those in the overweight group did not display unfavorable 
measures of VAT or CVD risk factors.  In fact, the average physical activity level in the 
current study was above the health recommendation of 30 minutes of physical activity on 
most days of the week (Armstrong et al., 2006).  Physical activity was recorded in 
minutes per day, on average, and was not exercise specific.  The current study found a 
negative correlation between VAT and physical activity (r = -.254 p = .042), a finding 
that grew stronger in obese individuals (r = -.574, p = .032).  This suggests that physical 
activity may help to lower VAT levels, thus lowering CVD risk.  Future research should 
focus on the roles of VAT and SCAT in a more diverse population, specifically those 
who may not be physically active, to determine how they are associated with BMI and 
CVD risk.   
The Framingham Heart Study currently uses BMI to measure obesity (Hubert et 
al., 1983).  However, more recent studies have argued that body fat distribution is more 
important that BMI calculations to determine CVD risk (Angeras et al., 2012; Fox et al., 
2007).  There is evidence that an apparently lean individual may be at greater risk for 
CVD than an obese individual, based on where the fat is located on the body (Angeras et 
al., 2012; Porter et al., 2006; Stefan et al., 2008).  Typically, SCAT is associated with hip 
circumference, whereas VAT is associated with WC (Hamdy et al., 2006).  This is one 
reason why some researchers believe that BMI is not sufficient to determine CVD risk.  
This theory is confirmed by the current study as shown by significant and strong positive 
correlations between SCAT and hip circumference (r = .780, p = .000).  VAT was 
moderately correlated with both hip circumference (r = .566, p = .000) and WC (r = .505, 
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p = .000) just as SCAT was correlated with WC (r = .535, p = .000), although these 
correlations are weaker. 
Effect of Age 
Age may be an important factor when evaluating CVD risk.  In the present study, 
individuals who were younger than 55 years old with increased VAT and SCAT 
exhibited a more unfavorable CVD risk profile compared with those who were 55 years 
and older.  This is not consistent with the literature, which suggests that CVD risk 
increases with age as a direct result of increased abdominal fat (DeNino et al., 2001; 
Nieves et al., 2003; Spangenburg et al., 2012).  Previous studies have concluded that 
VAT increases with age, and that this increase is associated with a more atherogenic lipid 
profile (DeNino et al., 2001; Nieves et al., 2003).  For women, the effect of age on VAT 
and CVD risk may be a result of the hormonal changes that take place after menopause.  
Without estrogen, VAT cells increase in size, thus potentially increasing the risk for CVD 
(Spangenburg et al., 2012).  This effect was found in animals, so it is only theoretically 
attributable to humans.  Spangenburg et al. (2012) stated that human studies are often 
affected by confounding variables, which could be one reason why the results of the 
current study did not support this finding.  One study suggested that obesity, measured by 
BMI, is associated with CVD risk (Stevens et al., 1998).  In conjunction with the current 
study, Stevens et al. (1998) determined that the association of obesity and relative risk of 
death and CVD is stronger for younger individuals than older individuals.  
 In the current study, the average age of participants was 56.16 years.  This is 
similar to the samples studied by DeNino et al. (2001) and Nieves et al. (2003).  DeNino 
et al. studied a population of women ages 20-78, dividing the participants into four age 
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groups: 20-35 years, 40-50 years, 51-60 years, and 61-78 years.  The youngest age group 
included nearly half of the participants, while the oldest age group consisted of less than 
one-quarter of the total sample.  The most significant differences between these groups 
with respect to VAT, SCAT, and TC were found between the first two groups and the last 
group, suggesting that VAT, SCAT, and TC increase significantly after the age of 50 
years (DeNino et al., 2001).  After controlling for VAT, the researchers determined that 
the increases in TC were a direct result of the increases in VAT.   
The results of the current do not support this theory and suggest that SCAT, but 
not VAT, is correlated with increased CVD risk as age increases.  SCAT was strongly 
associated with TC in the younger age group (r = .610, p = .000), and was still 
significantly correlated with the Framingham CVD risk score in the older group (r = .410, 
p = .022).  While VAT was not associated with any of the variables in the younger 
population, it did reach significance with TC in the older age group (r = -.420, p = .019) 
but not with the Framingham CVD risk score.  The relationship between SCAT and the 
Framingham CVD risk score seemed to be more affected by age than the relationship 
between VAT and the Framingham CVD risk score.  The results of the current study did 
not support previous research that VAT increases with age, warranting further research to 
determine if VAT is related to age or if another confounding factor could be associated 
with age that may affect CVD risk.  The disagreement between the current study and past 
research may be due to the limitations in the sample that was chosen for the current 
study.  Other study populations are larger in number and may have other variables that 
increase CVD risk other than abdominal fat.  The current sample is similar to most other 
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research based on age, but the small size and inability to control for other variables may 
have weakened the results of the study. 
Strengths and Limitations 
 The results of this study show that SCAT and VAT are strongly and positively 
correlated with the total US measurements.  Also, the individual components of the 
Framingham CVD risk score are strongly correlated with each other as well as with the 
score itself.  This adds strength to the current study, indicating that the measurements 
were consistent among all participants.  One limitation to this study is the measurement 
of VAT.  It is possible that the measurement of VAT was not an accurate measure as the 
VAT that sits in and around each organ may not have been included.  This may be one 
reason why there were lower amounts of VAT than expected in this study.  Validation 
studies should be performed on the BodyMetrix ultrasonography machine to determine 
its ability to measure VAT. 
This study was limited to a small, convenience sample from a homogenous 
population.  Age was the only delimitation, as this study was targeting older individuals.  
It was initially thought that the older population would be at greater risk for CVD due to 
the effects aging has on the body.  According to previous research, VAT levels are 
thought to increase as people age, thus increasing the risk for CVD (DeNino et al., 2001; 
Nieves et al., 2003).  The results of the current study did not support this theory, 
suggesting that another factor, such as fitness, may be linked to CVD risk more so than 
age.  The study population seems to exhibit traits that coincide with the fit and fat theory 
(Flegal et al., 2007).  Because there were no significant associations between VAT and 
the Framingham CVD risk score, it can be concluded that the sample may have been 
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healthy, even if they were considered overweight.  The current study agrees with Flegal 
et al. (2013) that evidence of CVD risk increases with levels of obesity.  Future research 
should divide the obese group into more specific groups based on BMI to determine any 
relationships between the grades of obesity.  
This study did not control for current diseases, medications, or family history.  
These variables may play a larger role in the development of CVD than was initially 
thought, although the sample size of the current study was too small to develop any 
theories with respect to these variables.  Future research should focus on obtaining a 
larger, more diverse population to analyze other variables that may be confounding the 
results of the current study.  It may be interesting to perform a follow-up study to 
determine how many people in the present study develop CVD 10 years from now, and 
how their levels of VAT and SCAT have changed over the years.   
Summary 
 The current study investigated the relationship between SCAT, VAT, the 
Framingham CVD risk score, and physical activity in older adults.  The results indicate 
that SCAT may be associated with CVD risk, and that this correlation strengthens with 
age.  Obese individuals as defined by BMI exhibit a more atherogenic CVD risk profile, 
independent of SCAT and VAT levels.  As expected, physical activity levels are 
negatively associated with abdominal obesity and CVD risk.  Although this study failed 
to determine an association of VAT and the Framingham CVD risk score, it will expand 
the literature regarding the role of SCAT and VAT in CVD risk identification and 
prevention. 
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